TCL Archive Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases August 26, 2011
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant June 26, 1998